<?xml version="1.1" encoding="utf-8"?>
<article xsi:noNamespaceSchemaLocation="http://jats.nlm.nih.gov/publishing/1.1/xsd/JATS-journalpublishing1-mathml3.xsd" dtd-version="1.1" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><front><journal-meta><journal-id journal-id-type="publisher-id">JCNR</journal-id><journal-title-group><journal-title>Journal of Clinical and Nursing Research</journal-title></journal-title-group><issn>2208-3685</issn><eissn>2208-3693</eissn><publisher><publisher-name>Bio-Byword Scientific Publishing Pty. Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.26689/jcnr.v8i7.7862</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title>Clinical Efficacy of Pentoxifylline Combined with Thioctic Acid in the Treatment of Painful Diabetic Peripheral Neuropathy</title><url>https://artdesignp.com/journal/JCNR/8/7/10.26689/jcnr.v8i7.7862</url><author>MaDengjuan,ZhangShilong,YaoPeng</author><pub-date pub-type="publication-year"><year>2024</year></pub-date><volume>8</volume><issue>7</issue><history><date date-type="pub"><published-time>2024-08-12</published-time></date></history><abstract>Objective: To observe the efficacy of pentoxifylline + thioctic acid in the treatment of patients with painful diabetic peripheral neuropathy (PDPN). Methods: 70 patients with PDPN admitted from October 2019 to October 2022 were selected and randomly grouped, with pentoxifylline + thioctic acid treatment in Group A and thioctic acid treatment in Group B, and the treatment efficacy was compared. Results: The treatment efficacy in Group A was higher than that of Group B, P &amp;lt; 0.05; the points of each symptom of PDPN in Group A were lower than that of Group B, P &amp;lt; 0.05; the C-reactive protein and electromyography indexes of PDPN patients in Group A were better than that of Group B, P &amp;lt; 0.05. Conclusion: PDPN patients treated with pentoxifylline + thioctic acid can optimize nerve function, inhibit inflammation progression, and reduce PDPN symptoms, which is an efficient and feasible treatment option.</abstract><keywords/></article-meta></front><body/><back><ref-list><ref id="B1" content-type="article"><label>1</label><element-citation publication-type="journal"><p>Wang X, 2021, Observation on the Therapeutic Effect of Thioctic Acid Combined with Pentoxifylline Extended-Release Tablets on Type 2 Diabetic Peripheral Neuropathy. Kang Yi, (11): 196.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B2" content-type="article"><label>2</label><element-citation publication-type="journal"><p>Guo W, Shi X, Liu D, et al., 2022, Clinical Study of Vitamin D2 Injection Combined with Thioctic Acid Injection in the Treatment of Patients with Type 2 Diabetes Mellitus Combined with Diabetic Peripheral Neuropathy. Chinese Journal of Clinical Pharmacology, 38(19): 2263–2267.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B3" content-type="article"><label>3</label><element-citation publication-type="journal"><p>Hao W, Sun T, Han X, et al., 2022, Clinical Effect Study of Alpha-Thioctic Acid Combined with Rehabilitation in the Treatment of Type 2 Diabetic Peripheral Neuropathy. China Modern Doctor, 60(11): 48–51.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B4" content-type="article"><label>4</label><element-citation publication-type="journal"><p>Wang Z, 2022, Effect of Alpha-Thioctic Acid Combined with Methylcobalamin on Inflammatory Response and Oxidative Stress Indexes in Patients with Type 2 Diabetic Peripheral Neuropathy. Reflexology and Rehabilitation Medicine, 3(13): 76–79.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B5" content-type="article"><label>5</label><element-citation publication-type="journal"><p>Wei R, Wen C, Liao X, 2022, Analysis of the Application effect of Alpha-Thioctic Acid Combined with Methylcobalamin Therapy in Patients with Type 2 Diabetic Peripheral Neuropathy. Diabetes Mellitus New World, 25(23): 184–187.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B6" content-type="article"><label>6</label><element-citation publication-type="journal"><p>Yu R, 2021, Effect of Alpha-Thioctic Acid Combined with Methylcobalamin on Oxidative Stress and TSS Score in Patients with Type 2 Diabetic Peripheral Neuropathy. Clinical Medicine, 41(12): 99–101.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B7" content-type="article"><label>7</label><element-citation publication-type="journal"><p>Zhang L, 2021, Discussion on the Total Effective Rate and Pharmacological Value of Using Alpha-Thioctic Acid and Methylcobalamin in the Treatment of Patients with Type 2 Diabetic Peripheral Neuropathy. Diabetes Mellitus New World, 24(15): 31–34.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B8" content-type="article"><label>8</label><element-citation publication-type="journal"><p>Qiu Y, Jiang X, Chen S, et al., 2020, Clinical Study of Pentoxifylline Combined with Methylcobalamin in the Treatment of Diabetic Peripheral Neuropathy. Modern Journal of Integrative Medicine, 29(3): 264–267.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B9" content-type="article"><label>9</label><element-citation publication-type="journal"><p>Feng Y, 2022, Therapeutic Effect of Pentoxifylline Combined with Methylcobalamin in the Treatment of Diabetic Peripheral Neuropathy. Contemporary Medicine Series, 20(17): 104–107.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B10" content-type="article"><label>10</label><element-citation publication-type="journal"><p>Li H, Hu B, Gong L, 2022, Therapeutic Effects of Alpha-Thioctic Acid Injection and Pentoxifylline Injection in the Treatment of Diabetic Peripheral Neuropathy. Chinese Health Care, 40(22): 53–56.</p><pub-id pub-id-type="doi"/></element-citation></ref></ref-list></back></article>
